Resolve Therapeutics, pioneering first-in-class, targeted, safe therapies for underserved autoimmune diseases, today announced that its phase 2 clinical trial of RSLV-132 in patients with long covid has been fully enrolled (NCT04944121).
An early pandemic survey found that respondents’ intentions to receive COVID-19 vaccines were linked more to their media literacy and opinion of health experts than knowledge of the virus or previous vaccination behavior.
As the COVID-19 pandemic settled in over the course of the first half of 2020, few authors enjoyed as much renewed interest as the Algerian-born French existentialist Albert Camus.
A new study conducted in England shows that the risk of death due to COVID-19 remains very low for children and young people, and most deaths occur in those with underlying health conditions. Marta Bertran of the UK Health Security Agency, London, and colleagues present these findings on November 8th in the open access journal PLOS Medicine.
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, demonstrated that withholding mycophenolate mofetil for 10 days significantly increased antibody response after 2 doses of COVID-19 vaccine, without a significant increase in flares.
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found a greater number of preterm births in unvaccinated versus fully vaccinated pregnant patients with rheumatic disease and COVID-19.
KIMM develops a rapid, automated molecular diagnosis system integrated with a non-face-to-face specimen collection robot. The system can complete the process of sample collection and molecular diagnosis within 40 minutes on site.
People living in the United States are more than three times more likely to share misinformation and conspiracy theories about COVID-19 than people in four other English-speaking countries, including Canada, a Simon Fraser University study has found.
Researchers at the University of Maryland School of Medicine’s (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They then used a drug to reverse the toxic effects of that protein on the heart.
Suggests a more proactive, innate immune response among females
After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists.
There continues to be inequities in access to bereavement support in the UK. In particular, even though minoritised ethnic communities were disproportionately affected by the COVID-19 pandemic, overall, proportions of ethnically minoritised clients did not increase, according to bereavement services.
Researchers comparing pre and post-pandemic surveys have found confidence in vaccinations is considerably lower post pandemic amongst all demographic groups.
During the COVID-19 pandemic in 2020, mortality risk for both COVID-19–positive and other patients on hemodialysis fluctuated in line with two waves of the pandemic in the general population.
During 4 waves of the COVID-19 pandemic in New York City, the risk of severe COVID-19 was associated with pre-existing chronic kidney disease, as well as heart disease, diabetes, and hypertension.
Though the COVID-19 pandemic disrupted many people’s social lives, new research from Michigan State University outlines some personality-related factors that may have contributed to students either continuing to form new relationships or avoiding them. The new study by MSU researchers found that one in five college students started a new romantic relationship during the pandemic.
The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.
Life on land may have quieted down during the height of the pandemic, but far offshore the Atlantic Ocean was just as active as ever according to a new study from the University of New Hampshire. Researchers found that there was no significant change in the continental shelf’s underwater soundscape during the year 2020— a surprising contrast to earlier reports of quieter coastal waters during that same timeframe.
• In a population-level study of 1,105 adults with stable glomerular disease (a type of autoimmune kidney disease), a first dose of a COVID-19 vaccine was not associated with relapse risk; however, receiving a subsequent vaccine dose was associated with a 2-fold higher relative risk of relapse. • Importantly, the increase in absolute risk associated with vaccination was low (1–5% depending on type of glomerular disease), and most vaccine-associated disease flares were mild.
Team members facilitated FaceTime calls and provided comfort care for Nazli Ozkilic’s father, who was in long-term care due to congestive heart failure
Using human brain organoids, an international team of researchers has shown how the SARS-CoV-2 virus that causes COVID-19 infects cortical neurons and specifically destroys their synapses — the connections between brain cells that allow them to communicate with each other.
Patients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than those who haven't received such therapies in the three months before their COVID diagnosis, show findings in a new study by researchers at Dana-Farber Cancer Institute, and across the U.S., Canada, and Mexico. Researchers found worse outcomes in both the disease itself as well as the fierce immune response that sometimes accompanies it.
A new model for understanding which patients with sepsis, Covid-19 and influenza have immune dysfunction and are more likely to suffer poor outcomes has been developed by researchers at the Wellcome Sanger Institute, the University of Oxford, Queen Mary University, Imperial College and their collaborators.
Data on more than 12,000 Britons also shows links with subsequent poor mental health, worse sleep, joblessness.
The difference in finger length between a person’s left and right hand may provide vital information about how ill they could get if they contract Covid-19.
Researchers from the University of Missouri School of Medicine have discovered a high prevalence of COVID-19 co-infections in central Missouri during the 2021-2022 flu season, with a monthly co-infection rate as high as 48% among individuals with COVID-19.
A pandemic survey found that adolescents who answered more COVID-19 test questions correctly also reported lower stress, anxiety and depression as well as lower loneliness and fear of missing out, also known as FOMO.
In one of the first studies to explore how COVID-19 specifically affects older infants, researchers from the University of Washington and at institutions at four other locations in the Western and Southern U.S. found that the number of infected people in a household was the factor most closely linked with the infant’s likelihood of being infected.
Respiratory illnesses are affected the United States as winter approaches, and a "tridemic" is possible with the flu, COVID-19 and RSV.
Adults with hypertension saw a small, but consequential, rise in their blood pressure levels during the first eight months of the COVID-19 pandemic, while the number of times they had their blood pressure measured dropped significantly, according to a study supported by the National Institutes of Health.
A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 vaccination.
Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease.
Hypertension control and management worsened during the early months of the COVID-19 pandemic, according to a new analysis conducted at three large health systems, led by Cedars-Sinai investigators.
COVID-19 vaccinations effectively reduce severe symptoms, hospitalizations, and death, which is why the Centers of Disease Control’s Advisory Committee on Immunization Practices will vote to add the COVID-19 vaccine to the recommended vaccine schedule for children.
Digital Framework Serves As Model for Large Health Systems During Future Pandemics
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
A Rutgers expert provides guidance to those who might be at increased risk during pregnancy
U.S. deaths from heart disease spiked in 2020 at the start of the COVID-19 pandemic after a steady decline from 2010 to 2019, reversing a public health success, according to preliminary research to be presented at the American Heart Association’s Scientific Sessions 2022.
UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms.
Roughly 21% of hospitalized COVID-19 patients at the height of the pandemic required an intensive care stay and the bulk were cared for by family upon discharge. However, not much is known about how these caregivers and patients adapted.
Research scientist Bobby Brooke Herrera, renowned for developing tools to accelerate diagnosis and treatment of infectious diseases such as COVID-19, has joined Rutgers Global Health Institute.
Temporary isolation wards utilized to house COVID-19 patients at a large Singapore hospital during the global pandemic allowed for safe management of COVID-19 cases over an 18-month period, without healthcare-associated SARS-CoV-2 transmission.
An article published in Science Advances suggests that a type of cancer treatment known as immune checkpoint blockade may be beneficial in certain cases of severe COVID-19.
A Yale-designed nasal vaccine can help bolster immune responses to COVID-19 in previously vaccinated animals and reduce viral transmission, Yale researchers report Oct. 27 in the journal Science.
Viral DNA in human genomes, embedded there from ancient infections, serve as antivirals that protect human cells against certain present-day viruses, according to new research.
Invitation for emergency medicine symposium
New research led by researchers at the University of Miami Miller School of Medicine and published in the Journal of Hepatology, suggests that getting a third dose of the COVID-19 mRNA vaccine could overcome the decreased vaccine respons in cirrhosis patients and offer strong protection against the virus, severe illness, and death from COVID-19.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
